相关实验视频

Updated: Jul 5, 2025

Murine Model of Allergen Induced Asthma

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

成年人喘的血蛋白签名

Gordon J Smilnak¹, Yura Lee², Abhijnan Chattopadhyay¹

¹Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.

|January 24, 2024

概括

这项研究确定了100多种与成人喘相关的血蛋白,为诊断提供了新的生物标志物,并为更好的喘管理提供了潜在的药物标.

科学领域:

蛋白质组学是指蛋白质组学.
生物标志物发现发现
呼吸系统医学呼吸系统医学

背景情况:

成人喘是一种复杂的疾病,其机制不完全理解.
血蛋白质组学为识别疾病生物标志物和阐明疾病途径提供了一个有希望的途径.
需要确定与成人喘相关的特定的血蛋白质组签名.

研究的目的:

为了识别与成人喘相关的血蛋白质组特征.
探索这些签名作为诊断生物标记物的潜力.
发现喘管理的新型治疗点.

主要方法:

利用SOMAScan 5K阵列测量两个大型队列中的血蛋白丰度:农业肺健康研究 (ALHS) 和社区动脉样硬化风险研究 (ARIC).
采用协变量调整后勤回归和反变量加权元分析来识别与喘相关的蛋白质.
在ALHS队列中研究了喘表型,包括具有和没有亚托皮的喘表型.

主要成果:

对4860种蛋白质的元分析显示,115种与喘有显著的关联 (FDR<0.05).
丰富分析确定了与气道炎症和肺损伤相关的信号通路.
一个机器学习衍生的蛋白质积分显示了喘的预测值 (AUC=0.72-0.77).
20种已识别的蛋白质是现有的或正在研究中的药物所准的,这表明了重用潜力.
喘形表型与20种蛋白质有关,其中包括5种新型蛋白质.

结论:

这项大规模的蛋白质组学研究是首次确定与成人喘相关的100多种血蛋白.
这些发现验证了以前的关联,并引入了新型蛋白质,有可能开发诊断生物标志物.
已识别的蛋白质可以作为治疗点,推进喘管理策略.

关键词:

过敏是一种过敏.曲线下的面积是曲线下的面积.生物标志物生物标志物精准医学是一门精准医学.蛋白质组学蛋白质组学

更多相关视频

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

相关概念视频

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...